Matrix metalloproteinases and tumor metastasis - PubMed (original) (raw)
Review
Matrix metalloproteinases and tumor metastasis
Elena I Deryugina et al. Cancer Metastasis Rev. 2006 Mar.
Abstract
Functions of individual matrix metalloproteinases (MMPs) differentially expressed by tumor cells and stromal cells, are finely regulated by their spatial as well as temporal interactions with distinct cellular and extracellular components of the tumor microenvironment and also distant pre-metastatic sites. Certain aspects of MMP involvement in tumor metastasis such as tumor-induced angiogenesis, tumor invasion, and establishment of metastatic foci at the secondary site, have received extensive attention that resulted in an overwhelming amount of experimental and observational data in favor of critical roles of MMPs in these processes. In particular, dependency of tumor angiogenesis on the activity of MMPs, especially that of MMP-9, renders this step possibly the most effective target of synthetic MMP inhibitors. MMP functioning in other stages of metastasis, including the escape of individual tumor cells from the primary tumor, their intravasation, survival in circulation, and extravasation at the secondary site, have not yet received enough consideration, resulting in insufficient or controversial data. The major pieces of evidence that are most compelling and clearly determine the role and involvement of MMPs in the metastatic cascade are provided by molecular genetic studies employing knock-out or transgenic animals and tumor cell lines, modified to overexpress or downregulate a specific MMP. Findings from all of these studies implicate different functional mechanisms for both tumor and stromal MMPs during distinct steps of the metastatic cascade and indicate that MMPs can exhibit pro-metastatic as well as anti-metastatic roles depending on their nature and the experimental setting. This dual function of individual MMPs in metastasis has become a major focus of this review.
Similar articles
- The other side of MMPs: protective roles in tumor progression.
Martin MD, Matrisian LM. Martin MD, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):717-24. doi: 10.1007/s10555-007-9089-4. Cancer Metastasis Rev. 2007. PMID: 17717634 Review. - Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI, Werb Z. Littlepage LE, et al. Cancer Res. 2010 Mar 15;70(6):2224-34. doi: 10.1158/0008-5472.CAN-09-3515. Epub 2010 Mar 9. Cancer Res. 2010. PMID: 20215503 Free PMC article. - Roles of matrix metalloproteinases in tumor metastasis and angiogenesis.
Yoon SO, Park SJ, Yun CH, Chung AS. Yoon SO, et al. J Biochem Mol Biol. 2003 Jan 31;36(1):128-37. doi: 10.5483/bmbrep.2003.36.1.128. J Biochem Mol Biol. 2003. PMID: 12542983 Review. - Matrix metalloproteinases: multifunctional contributors to tumor progression.
McCawley LJ, Matrisian LM. McCawley LJ, et al. Mol Med Today. 2000 Apr;6(4):149-56. doi: 10.1016/s1357-4310(00)01686-5. Mol Med Today. 2000. PMID: 10740253 Review. - Matrix metalloproteinases and the thyroid.
Kraiem Z, Korem S. Kraiem Z, et al. Thyroid. 2000 Dec;10(12):1061-9. doi: 10.1089/thy.2000.10.1061. Thyroid. 2000. PMID: 11201850 Review.
Cited by
- Fullerene Derivatives for Tumor Treatment: Mechanisms and Application.
Hou W, Shen L, Zhu Y, Wang X, Du T, Yang F, Zhu Y. Hou W, et al. Int J Nanomedicine. 2024 Sep 23;19:9771-9797. doi: 10.2147/IJN.S476601. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39345909 Free PMC article. Review. - Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer.
Tamura K, Tomita Y, Kanazawa T, Shinohara H, Sakano M, Ishibashi S, Ikeda M, Kinoshita M, Minami J, Yamamoto K, Kato Y, Furukawa A, Haruki S, Tokunaga M, Kinugasa Y, Kurata M, Kitagawa M, Ohashi K, Yamamoto K. Tamura K, et al. Int J Mol Sci. 2024 Aug 24;25(17):9203. doi: 10.3390/ijms25179203. Int J Mol Sci. 2024. PMID: 39273151 Free PMC article. - Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma.
Wang X, Yang Y, Zhao S, Wu D, Li L, Zhao Z. Wang X, et al. Front Pharmacol. 2024 Aug 5;15:1446030. doi: 10.3389/fphar.2024.1446030. eCollection 2024. Front Pharmacol. 2024. PMID: 39161903 Free PMC article. Review. - Vitamin B6 deficiency cooperates with oncogenic Ras to induce malignant tumors in Drosophila.
Pilesi E, Tesoriere G, Ferriero A, Mascolo E, Liguori F, Argirò L, Angioli C, Tramonti A, Contestabile R, Volontè C, Vernì F. Pilesi E, et al. Cell Death Dis. 2024 Jun 3;15(6):388. doi: 10.1038/s41419-024-06787-3. Cell Death Dis. 2024. PMID: 38830901 Free PMC article. - Molecular mechanisms of extracellular-ATP-mediated colorectal cancer progression: Implication of purinergic receptors-mediated nucleocytoplasmic shuttling of HuR.
Shatat AS, Mahgoup EM, Rashed MH, Saleh IG, Akool ES. Shatat AS, et al. Purinergic Signal. 2024 May 27. doi: 10.1007/s11302-024-10021-2. Online ahead of print. Purinergic Signal. 2024. PMID: 38801618
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous